1-2 of 2
Dorella Franchi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Utility of Risk Models to Refer Patients with Adnexal Masses to Specialized Oncology Care: Multicenter External Validation Using Decision Curve Analysis

Laure Wynants, Dirk Timmerman, Jan Y. Verbakel, Antonia Testa, Luca Savelli, Daniela Fischerova, Dorella Franchi, Caroline Van Holsbeke, Elisabeth Epstein, Wouter Froyman, Stefano Guerriero, Alberto Rossi, Robert Fruscio, Francesco PG Leone, Tom Bourne, Lil Valentin, Ben Van Calster
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (17): 5082–5090.
https://doi.org/10.1158/1078-0432.CCR-16-3248
Published: 31 August 2017
View article titled, Clinical Utility of Risk Models to Refer Patients with Adnexal Masses to Specialized Oncology Care: Multicenter External Validation Using Decision Curve Analysis
Open the PDF for Clinical Utility of Risk Models to Refer Patients with Adnexal Masses to Specialized Oncology Care: Multicenter External Validation Using Decision Curve Analysis in another window
Includes: Supplementary data
Journal Articles

A Two-by-Two Factorial Trial Comparing Oral with Transdermal Estrogen Therapy and Fenretinide with Placebo on Breast Cancer Biomarkers

Andrea Decensi, Bernardo Bonanni, Laura Baglietto, Aliana Guerrieri-Gonzaga, Francesca Ramazzotto, Harriet Johansson, Chris Robertson, Irene Marinucci, Frederique Mariette, Maria Teresa Sandri, Cristina Daldoss, Vanda Bianco, Marco Buttarelli, Massimiliano Cazzaniga, Dorella Franchi, Enrico Cassano, Umberto Omodei
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (13): 4389–4397.
https://doi.org/10.1158/1078-0432.CCR-04-0087
Published: 06 July 2004
View article titled, A Two-by-Two Factorial Trial Comparing Oral with Transdermal Estrogen Therapy and Fenretinide with Placebo on Breast Cancer Biomarkers
Open the PDF for A Two-by-Two Factorial Trial Comparing Oral with Transdermal Estrogen Therapy and Fenretinide with Placebo on Breast Cancer Biomarkers in another window